CTI Clinical Trial and Consulting Services Announces that Ralph Campaneria, MD has joined as Medical Director
[Cincinnati, OH ~ August 23, 2013] CTI Clinical Trial and Consulting Services (CTI) announces the hiring of Dr. Ralph Campaneria as Medical Director.
Prior to joining CTI, Dr. Campaneria was with Inhibitex, a biopharmaceutical company, where he served as Medical Director and led the development of several Hepatitis C programs. Dr. Campaneria also spent nearly ten years in multiple roles at Monitoring Force, an international Clinical Research Organization (CRO), conducting Phase II, III, and IV trials. Throughout his time with Monitoring Force, Dr. Campaneria managed global regulatory and clinical trial programs, and he held the position of Medical Monitor/Director, Director of Clinical Operations, and finally as CEO. Dr. Campaneria has worked in the CRO and Biopharmaceutical industry for the past ten years, and he has broad experience across the spectrum of drug development including medical monitoring, pharmacovigilance, project management, key opinion leader relationship development, medical evaluation risk assessment, drug safety reporting, regulatory filings, and regulatory document development. His therapeutic background includes industry and clinical experience in hematology, dermatology, immunology, infectious disease, and psychiatry. Dr. Campaneria earned his Doctor of Medicine from East Central University School of Medicine.
“We are very excited that Dr. Campaneria has joined our established medical team, as he brings a wealth of global clinical research and drug development experience in the biotech industry,” according to Lynn Fallon, Executive Vice President at CTI Clinical Trial and Consulting Services and President, Consulting Services. “His talents and knowledge are great compliments to the rest of our expert team of medical directors.”
About CTI Clinical Trial and Consulting Services
CTI Clinical Trial and Consulting Services is an innovative, international drug and device development organization that delivers a full spectrum of clinical trial and consulting services from bench to commercialization with a focus on immunology and a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology and startup firms with clinical and disease area expertise from a unique mix of academic, medical and industry specialists; rich intellectual capital in transplantation, immunology, infectious diseases, hematology, cardiology, nephrology, hepatology, regenerative medicine and rare diseases; flexible study designs that accelerate development programs and delivers high approval ratings that are among the best in the industry; and exceptional global project management and gold standard safety and data management systems that strengthen their program’s success potential. Established in 1999 and headquartered in Cincinnati, OH; CTI has offices in North America, Europe and South America.
CTI Clinical Trial and Consulting Services
10123 Alliance Road
Cincinnati, OH 45242
Follow us on Twitter @CTIClinical
Where Life-changing Therapies Turn First™
Posted: August 2013